Average Co-Inventor Count = 8.45
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Irm LLC (13 from 151 patents)
2. Novartis Ag (11 from 3,923 patents)
3. Other (2 from 832,680 patents)
20 patents:
1. 11427586 - 1,2,4-oxadiazole derivatives as liver X receptor agonists
2. 9751876 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
3. 9199981 - Compounds and compositions as C-kit kinase inhibitors
4. 9102671 - Compounds and compositions as TRK inhibitors
5. 9073921 - Salt forms of bicyclic heterocyclic derivatives
6. 9023839 - Compounds and compositions as c-kit kinase inhibitors
7. 8883819 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
8. 8754071 - Compounds and compositions as c-kit kinase inhibitors
9. 8637516 - Compounds and compositions as TRK inhibitors
10. 8569283 - Compounds and compositions as c-Kit kinase inhibitors
11. 8338417 - Compounds and compositions as c-kit and PDGFR kinase inhibitors
12. 8293757 - 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
13. 8288540 - 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
14. 8278452 - Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
15. 8106068 - Compositions and methods for modulating c-kit and PDGFR receptors